Nvidia breaks $1000, big banks increase their targets even higher

Today’s big movers inside                                                                                                                                                                                                                                                                                                                                                                                                                 May 23, 2024 Nvidia breaks $1000, big banks increase their targets even higher Join Jason today for a special session in the [MOTHERSHIP]( where he is dialing in the power of momentum stocks in his challenge to turn $25k into $1M. Hey, if you don’t swing for the fences, why swing at all? He’s killing it right now in [Jason Bond Picks]( and the action is thrilling. Be a mother and get in there! FOCUS LIST🔎 ONMD - Up over 50% in the pre-market after reporting greater than 5x expansion of iRWD™ network and platform RAMP - Up over 15% in pre after reporting better than expected earnings   NVDA - Up over 7% in pre after crushing earnings, Bof A raises price target to $1320 *sponsored by Interactive Offers “Bird Flu” is trending again in the news, as we just had the[second report]( of it spreading to humans in the US. This brings to mind a familiar stock we mentioned a couple weeks ago that is now trading over 30% higher. Pull up NanoViricides (NNVC) on your platform right now. When I first brought this idea to your attention a couple of weeks ago, I asked, “What if NNVC is just getting started?” That was when the Bird Flu stories were just getting attention, and NNVC was 30% lower than it is right now. Well, look at how the stock has reacted since that first alert… Since then, NNVC has hit a new 52-week high several times, and it is within a few cents of doing that again today. That is quite simply one of the strongest trends in the whole market right now. Unless there is a miracle cure for this disease, I think there will only be more traders finding this stock. That is why it is important you carefully look at NNVC right now. There has been a lot of news for NNVC lately. Make sure you are keeping up with all of it. This is a fast-moving situation. Spend time doing your own research, as trading is risky and nothing is guaranteed. You can access [our report here]( and their recent[announcement here]( about the development of an antiviral drug. In fact, just moments ago, NNVC [announced]( that it was bolstering a key partnership. Bottom line: While the stock might be a little stretched right now, it is impossible to know where a story like this will carry the price to. NNVC is a fast-developing situation and it should be on your radar 📡. *Sponsored content/paid advertisement. This investment involves substantial risk. Please see full disclosure below, and detailed discussion of risks and atypical results. HOTLIST🔥 ONMD - Up over 50% in the pre-market after reporting greater than 5x expansion of iRWD™ network and platform OneMedNet Corporation (ONMD) provides clinical imaging solutions. It offers iRWD (Real World Data), a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. In the pre-market this morning the [company announced]( a greater than expected five fold expansion of its iRWD™ network and platform. Through a series of new network partnership agreements, including one recently signed with an undisclosed nation-wide medical records custodian, OneMedNet is now offering its growing base of customers seamless access to an expanded set of RWD across its robust network comprised of: -1,402 healthcare system and provider partner sites; -31.0 million patients; and -121.4 million clinical exams. The year-to-date increases in partner sites, patients and clinical exams represent growth of 472%, 170% and 122%, respectively, since the end of 2023. The stock traded up over 50% in the pre-market in reaction to the news. The first target for bulls is the pre-market high at $1.20. Above it, targets to the upside are $1.30, $1.50 and then $2. Below $1.20, targets to the downside are $1.10, $1, $0.90, $0.80, $0.70, $0.58 and then a gap fill at $0.49. RAMP - Up over 15% in pre after reporting better than expected earnings LiveRamp Holdings, Inc. (RAMP) is a technology company that operates a data collaboration platform in the United States and internationally. In the after-hours yesterday, the [company reported]( its financial results for the quarter and fiscal year ended March 31, 2024. Highlights include: Q4 Revenue up 16% year-over-year Q4 Subscription Revenue up 11% year-over-year FY24 Operating Cash Flow of $106 million versus $34 million a year ago Total revenue was $172 million, up 16%. Subscription revenue was $134 million, up 11%. Marketplace & Other revenue was $38 million, up 38%. GAAP gross profit was $124 million, up 18%. GAAP operating loss was $14 million compared to $47 million. GAAP diluted loss per share was $0.08 and non-GAAP diluted earnings per share was $0.25. Net cash provided by operating activities was $28 million compared to $31 million. Share repurchases in the fourth quarter totaled approximately 405,000 shares for $15 million. The stock traded up over 15% in the pre-market in reaction to the earnings results. The $37 was resistance in the after-hours and now becomes a potential support level. Above it the first target for bulls is the after-hours high at $38.05. Beyond that, $39, $40 and $42 come into play. Below $37, targets to the downside are $36, $35, $34, $33 and then a gap fill at $32.34. Fight Trader’s Block 🤺 With 12 Months of Access to Jason’s Top 0DTE & Penny Stocks Each Day Learn how he’s locked in winners like these: *Note: Trading is hard, results not guaranteed and should not be expected to be replicated typically. Current Balance is Rockin’ *Note: Trading is hard, results not guaranteed and should not be expected to be replicated typically. [Get Excited About Trading Again!]( NVDA - Up over 7% in pre after crushing earnings, Bof A raises price target to $1320 NVIDIA Corporation (NVDA) provides graphics and compute and networking solutions in the United States and internationally. In the after hours yesterday the [company reported]( better-than-expected Q1 2025 financial results and issued Q2 2025 revenue guidance with its midpoint above estimates. Also, the company announced a 10-for-1 forward stock split effective June 7, 2024 and increased its quarterly dividend per share on a post-split basis. Highlights include: NVDA reported record quarterly revenue of $26.0 billion, up 18% from Q4 and up 262% from a year ago Record quarterly Data Center revenue of $22.6 billion, up 23% from Q4 and up 427% from a year ago Quarterly cash dividend raised 150% to $0.01 per share on a post-split basis The stock traded up over 7% in the pre-market in reaction to the earnings report. The first target for bulls is the after-hours high at $1023.44. Beyond that, targets to the upside are round numbers such as $1030, $1040, $1050 and $1100. Below $1023.44, targets to the downside are $1010, $1005, $1000, $980, $960 and then a gap fill at $949.50. MARKET NEWS 📰 👊 Make sure you are getting my mobile text alerts –  text “RAGE” to 1-(888) 404-5747 to get all of my latest HOT STOCK ideas delivered right to your phone (make sure you put the “1” at the front!). Don’t miss out! Questions or concerns about our products? Email [Support@360wallstreet.io]( © Copyright 2022, RagingBull *Just so you know, what you're reading is curated content for which we have received a monetary fee (detailed below) to create and distribute. Let's be clear that investing can be quite the roller coaster as stock prices can have wild swings up and down, so consider those crucial risks before you ever consider trading anything we discuss. Make sure you check out our full disclosure down below for the details on how we were paid, the risks, and why these results aren't what you'd call “typical.” Just a quick heads up about this ad you're reading—as we’ve said, even though we like the company referenced above, and all the facts we discussed above are true to the best of our knowledge, we are running a business here. To distribute this information and help offset the costs of maintaining our large digital audience, in advance of writing the content above, we received seventeen thousand dollars (cash) from Interactive Offers for advertising NanoViricides, Inc for a one day marketing program on May 23, 2024. We also previously received seventeen thousand dollars (cash) from Interactive Offers for advertising NanoViricides, Inc for a one day marketing program on may 8, 2024. This amount was paid by someone else not connected to NanoViricides, Inc. It might be obvious, but whoever paid for this might own shares and is likely looking to sell some or all of them at any time after we send out this information, which might affect the stock price. We may also buy or sell shares in the company at some point in the future, although neither RagingBull nor its owners own any shares of the company at this time. Also, keep in mind that due to the sheer size of our audience, if even a small percentage of people decide they want to buy this stock, it could potentially boost interest enough to hike up those share prices and cause a temporary spike, and the opposite is possible as our program ends, though that is not always the case. Now, diving right into NanoViricides, Inc might sound exciting. But remember, it’s like venturing into the wilderness—be aware that there's exceptional risk involved in trading. This isn't small potatoes we're talking about; you could lose every dime you put in, so always carefully think about what you’re doing. That’s why they call this trading, after all. We're shining a light on the good stuff about the company here, but it's on you to do your homework, make your own calls, and determine a plan for your own trading, hopefully with the help of your professional 1nvestment advis0r. Oh, that brings us to another crucial point—we're not here to tell you (or even recommend) what you should do with your hard-earned money. We’re simply sharing our non-expert thoughts by highlighting some companies we like that could use some help telling their story to more people. We’re obviously biased in our writing. We’re not here to dig into anything that may be negative about the company; this is advertising, after all! Also, keep in mind that if we make some predictions about the future, these are technically known as “forward-L00king statements” under the securities acts, so take those with a grain of salt. As with all forecasts, they’re not set in stone, often wrong, and we certainly can’t know where the Company’s earnings, business, or share price will be tomorrow or a year from now. Everything you read from us is all for your education, information, and possible entertainment. While we believe the info is reliable and accurate, we can't wear a cape and guarantee it. Before you jump into anything, make sure to talk it over with a pro—someone you trust who's licensed to give you real advice. To be clear, Neither Raging Bull nor its owners, employees, or independent contractors are registered as a secur1ties br0ker-dealer, br0ker, 1nvestment advis0r (IA), or IA rep’s with the SEC, any state securities regulat0ry authority, or any self-regulat0ry organization. So, that's the scoop! If you're intrigued and want to learn more about the companies we talk about, hit up the SEC's website to dig into their filings and see the full picture. [tw]( Update your email preferences or unsubscribe [here]( © 2024 360 WallStreet 62 Calef Hwy. #233 lee, NH 03861, United States of America